It is possible that blood-brain barrier (BBB) breaches could have been induced by bapineuzumab or autoantibodies generated by the high amounts of Ab in addition to a vascular inflammatory reaction
In addition, bapineuzumab immunotherapy could be constrained in its consequences because its specific epitope...